...
首页> 外文期刊>The Canadian journal of cardiology >Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: An evaluation of the RISK-PCI data
【24h】

Sex-related analysis of short- and long-term clinical outcomes and bleeding among patients treated with primary percutaneous coronary intervention: An evaluation of the RISK-PCI data

机译:初次经皮冠状动脉介入治疗患者中短期和长期临床结局与出血的性别相关分析:RISK-PCI数据评估

获取原文
获取原文并翻译 | 示例

摘要

Background: Unfavourable effect of female sex on short- and long-term clinical outcomes has been demonstrated in unselected ST-elevation acute myocardial infarction (STEMI) patients; the results are conflicting in patients who undergo primary percutaneous coronary intervention (PPCI). The objective of this substudy was to determine whether there are sex-related differences in the 30-day and 1-year clinical outcomes and bleeding after PPCI for STEMI. Methods: We analyzed 2096 STEMI patients enrolled in the Risk Scoring Model to Predict Net Adverse Cardiovascular Outcomes After Primary Percutaneous Coronary Intervention (RISK-PCI) trial from February 2006 to December 2009. Composite efficacy end point comprised all-cause mortality, nonfatal infarction, and stroke. Safety end point was bleeding classified according to the Thrombolysis in Myocardial Infarction (TIMI) criteria. Net adverse cardiovascular events included composite efficacy end point and total bleeding. Results: Women in our study were older and presented later than men. After adjustment for potential confounders, there was no difference between sexes with respect to the composite efficacy end point. A higher rate of total bleeding was observed in women (adjusted odds ratio [OR], 1.67; 95% confidence interval [CI], 1.07-2.61 at 30 days, adjusted OR, 1.63; 95% CI, 1.08-2.47 at 1 year) compared with men. Total bleeding was associated with increased mortality at 30 days (OR, 4.87; 95% CI, 2.79-8.47) and at 1 year (OR, 4.43; 95% CI, 2.79-7.02) after PPCI. Conclusions: We did not find a significant sex-related difference with respect to the composite efficacy end point. Women had a higher rate of total bleeding which was associated with increased short- and long-term mortality. Specific measures aimed at preventing bleeding in women might improve the prognosis of PPCI patients.
机译:背景:未选出的ST段抬高型急性心肌梗死(STEMI)患者已证明女性对短期和长期临床结局不利。在接受初次经皮冠状动脉介入治疗(PPCI)的患者中,结果矛盾。这项研究的目的是确定STEMI的PPCI后30天和1年临床结果和出血是否存在性别相关差异。方法:我们分析了2006年2月至2009年12月在初次经皮冠状动脉介入治疗(RISK-PCI)试验后纳入风险评分模型的2096名STEMI患者,以预测其净不良心血管结局。综合疗效终点包括全因死亡率,非致命性梗死,和中风。安全终点是根据心肌梗塞溶栓(TIMI)标准分类的出血。净不良心血管事件包括复合功效终点和总出血。结果:在我们的研究中,女性比男性年龄大,出现晚。在对潜在的混杂因素进行调整后,就综合功效终点而言,性别之间没有差异。女性的总出血率更高(30天调整后的优势比[OR]为1.67; 95%置信区间[CI]为1.07-2.61;调整后的OR为1.63; 95%CI为1.08-2.47) )与男性相比。 PPCI后30天(OR,4.87; 95%CI,2.79-8.47)和1年时(OR,4.43; 95%CI,2.79-7.02)总出血与死亡率增加相关。结论:在综合疗效终点方面,我们没有发现明显的性别相关差异。妇女的总出血率较高,这与短期和长期死亡率的增加有关。旨在防止女性出血的特定措施可能会改善PPCI患者的预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号